Belize
UNDP, working in partnership with the Global Fund and national partners, has provided HIV counselling and testing encounters for 887,000 people and put 68,300 people on treatment.
Key results - HIV
With the highest HIV prevalence in Central America, combined with over half of the population being under 25 years of age, Belize faces significant social and economic challenges. Although still fairly modest in size TB/HIV coinfection has seen a trend of increase in the last decade and there remain challenges in supporting all TB patients to achieve successful treatment.
Read more...
UNDP assumed the role of Principal Recipient (PR) for Global Fund HIV grants in Belize in 2011, and in 2016 became PR for the joint HIV/TB programme. The HIV grants have combatted key drivers of the disease including poverty, unemployment, chronic malnutrition, and drug abuse, by targeting young people and key populations at higher risk, such as men who have sex with men and female sex workers. The current programme focusses on increasing testing and counselling services among men, in priority districts and amongst priority age groups (19-24 and 40-49 years), improving retention on antiretroviral therapy and reducing stigma discrimination as barriers to prevention and treatment. The TB programme aims to strengthen the overall health system’s capacity to manage TB, TB/HIV, and MDR-TB, with a significant focus on training key aspects of the health system to play their role in the TB response. UNDP has been confirmed to continue managing the HIV/TB programme to 2021 with the focus of efforts being on strengthening resilient and sustainable systems for health and increasing domestic financing to ensure the gains achieved are sustained.
Belize has a formal Capacity Development Plan in place and transition to a national Principal Recipient is under review
101,000 counselling and testing encounters for HIV
Source: UNDP
1,400 people currently on ART (2017)
Source: UNDP
New cases of HIV
Source: UNAIDS
HIV-positive TB patients on Antiretroviral Therapy
Source: World Health Organization
Maternal and infant mortality rates
Source: World Health Organization
Grant details
Disease
HIV / TB
Grant
BLZ-C-UNDP
Phase
Period 1 (Jan 2016 - Dec 2018)
Amount
$3,359,024
Rating
